Tumor necrosis factor-α: A new mechanism of ischemic ventricular fibrillation?

Chinese Medical Journal

Volumn 121, Issue 18, 2008, Pages 1848-1851

  Xiao, Hua ^a   Liao, Yu Hua ^a   Chen, Zhi Jian ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Arrhythmias; Cardiac; Ischemic ventricular fibrillation; Tumor necrosis factor alpha

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ARTICLE; CYTOKINE PRODUCTION; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MOLECULAR MECHANICS; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN SECRETION; SUDDEN DEATH;

EID: 54349085409     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200809020-00017     Document Type: Article

References (39)

1. Chen YG, Xu F, Zhang Y, Ji QS, Sun Y, Lü RJ, et al. Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome. Chin Med J 2006; 119: 32-36.
2. Valgimigli M, Ceconi C, Malagutti P, Merli E, Soukhomovskaia O, Francolini G, et al. Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study. Circulation 2005; 111: 863-870.
3. Sun M, Dawood F, Wen WH, Chen M, Dixon I, Kirshenbaum LA, et al. Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction. Circulation 2004; 110: 3221-3228.
4. Wada H, Saito K, Kanda T, Kobayashi I, Fujii H, Fujigaki S, et al. Tumor necrosis factor-α plays a role in actual viral myocarditis in mice. Circulation 2001; 103: 743-749.
5. Satoh M, Nakamura M, Saitoh H, Satoh H, Maesawa C, Segawa I, et al. Tumor necrosis factor-alpha converting enzyme and tumor necrosis factor-alpha in human dilated cardiomyopathy. Circulation 1999; 99: 3260-3265.
6. Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS, et al. Targeted anticytokine therapy in patients with chronic heart failur: results of the randomized etanercept worldwide evaluation (RENEWAL). Circulation 2004; 109: 1594-1602.
7. Li W, Gan R, Sun G. Chronic treatment of enbrel in rats with isoproterenol-induced congestive heart failure limits left ventricular dysfunction and remodeling. Chin Med J 2002; 115: 1166-1169.
8. Zhao J, Qu XF, Zhao CY, Cao FL, Zhou T, Li WM, et al. Effects of metoprolol treatment on a disintegrin metalloproteinase expression and extracellular matrix remodeling after myocardial infarction in rats. Chin Med J 2007; 120: 1549-1552.
9. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
10. Irwin MW, Mak S, Mann DL, Qu R, Penninger JM, Yan A, et al. Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation 1999; 99: 1492-1498.
11. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002; 53: 31-47.
12. Berthonneche C, Sulpice T, Boucher F, et al. New insights into the pathological role of TNF-alpha in early cardiac dysfunction and subsequent heart failure after infarction in rats. Am J Physiol Heart Circ Physiol 2004; 287: H340-H350.
13. Siwik DA, Colucci WS. Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium. Heart Fail Rev 2004; 9: 43-51.
14. Li B, Liao YH, Cheng X, Ge H, Guo H, Wang M. Effects of carvedilol on cardiac cytokines expression and remodeling in rat with acute myocardial infarction. Int J Cardiol 2006; 111: 247-255.
15. Liao YH, Cheng X. Autoimmunity in myocardial infarction. Int J Cardiol 2006; 112: 21-26.
16. Lee SH, Chen YC, Chen YJ, Chang SL, Tai CT, Wongcharoen W, et al. Tumor necrosis factor-alpha alters calcium handling and increases arrhythmogenesis of pulmonary vein cardiomyocytes. Life Sci 2007; 80: 1806-1815.
17. Ishida K, Kimura F, Imamaki M, Ishida A, Shimura H, Kohno H, et al. Relation of inflammatory cytokines to atrial fibrillation after off-pump coronary artery bypass grafting. Eur J Cardiothorac Surg 2006; 29: 501-505.
18. Saba S, Janczewski AM, Baker LC, Shusterman V, Gursoy EC, Feldman AM, et al. Atrial contractile dysfunction, fibrosis, and arrhythmias in a mouse model of cardiomyopathy secondary to cardiac-specific overexpression of tumor necrosis factor-α. Am J Physiol Heart Circ Physiol 2005; 289: H1456-1467.
19. London B, Baker LC, Lee JS, Shusterman V, Choi BR, Kubota T, et al. Calcium-dependent arrhythmias in transgenic mice with heart failure. Am J Physiol Heart Circ Physiol 2003; 284: H431-441.
20. Marketou ME, Simantirakis EN, Nikitovic D, Chrysostomakis SI, Zacharis EA, Vardas PE. Impact of asynchronous ventricular activation on pro-inflammatory cytokines and oxidative stress in paced patients. Heart 2005; 91: 817-818.
21. Xia HJ, Dai DZ, Dai Y. Up-regulated inflammatory factors endothelin, NFkappaB, TNFalpha and iNOS involved in exaggerated cardiac arrhythmias in l-thyroxine-induced cardiomyopathy are suppressed by darusentan in rats. Life Sci 2006; 79: 1812-1819.
22. Wang J, Wang H, Zhang Y, Gao H, Nattel S, Wang Z. Impairment of HERG K+ Channel Function by Tumor Necrosis Factor-α. J Biol Chem 2004; 279: 13289-13292.
23. Konstantino Y, Kusniec J, Reshef T, David-Zadeh O, Mazur A, Strasberg B, et al. Inflammatory biomarkers are not predictive of intermediate-term risk of ventricular tachyarrhythmias in stable CHF patients. Clin Cardiol 2007; 30: 408-413.
24. Janse MJ, Wit AL. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev 1989; 69: 1049-1169.
25. Cascio WE, Yang H, Muller-Borer BJ, Johnson TA. Ischemia-induced arrhythmia: the role of connexins, gap junctions, and attendant changes in impulse propagation. J Electrocardiol 2005; 38: 55-59.
26. Coronel R, Wilms-Schopman FJ, deGroot JR. Origin of ischemia-induced phase 1b ventricular arrhythmias in pig hearts. J Am Coll Cardiol 2002; 39: 166-176.
27. Luqman N, Sung RJ, Wang CL, Kuo CT. Myocardial ischemia and ventricular ibrillation: pathophysiology and clinical implications. Int J Cardiol 2007; 119: 283-290.
28. Kaplinsky E, Ogawa S, Balke CW, Dreifus LS. Two periods of early ventricular arrhythmia in the canine acute myocardial Chinese Medical Journal 2008; 121(18):1848-1851 1851 infarction model. Circulation 1979; 60: 397-403.
29. Kleber AG. Resting membrane potential, extracellular potassium activity and intracellular sodium activity during acute global ischemia in isolated perfused guinea pig hearts. Circ Res 1983; 52: 442-450.
30. Pinet C, Le Grand B, John GW, Coulombe A. Coulombe, Thrombin facilitation of voltage-gated sodium channel activation in human cardiomyocytes: implications for ischemic sodium loading. Circulation 2002; 106: 2098-2103.
31. Beardslee MA, Lerner DL, Tadros PN, Laing JG, Beyer EC, Yamada KA, et al. Dephosphorylation and intracellular redistribution of ventricular connexin 43 during electrical uncoupling induced by ischemia. Circ Res 2000; 87: 656-662.
32. Lameris TW, van Den Meiracker AH, Boomsma F, Alberts G, de Zeeuw S, Duncker DJ, et al. Time course and mechanism of myocardial catecholamine release during transient ischemia in vivo. Circulation 2000; 101: 2645-2650.
33. Sachs F. Mechanoelectric transduction. In: Zipes DP and Jalife J, Editors. Cardiac electrophysiology: From cell to bedside. Philadelphia: WB Saunders; 2004: 96-102.
34. Coronel R, Wilms-Schopman FJ, Dekker LRC, Janse MJ. Heterogenetities in [K+] and TQ potential and the inducibility of ventricular fibrillation during acute regional ischemia in the isolated perfused porcine heart. Circulation 1995; 92: 120-129.
35. Zaitsev AV. Mechanism of ischemic ventricular fibrillation: who's the killer? In: Zipes DP and Jalife J, Editors. Cardiac electrophysiology: From cell to bedside. Philadelphia: WB Saunders; 2004: 399-406.
36. Opthof T, Coronel R, Vermeulen JT, Verberne HJ, van Capelle FJ, Janse MJ. Dispersion of refractoriness in normal and ischaemic canine ventricle: effects of sympathetic stimulation. Cardiovasc Res 1993; 27: 1954-1960.
37. Shimoda Y, Satoh M, Nakamura M, Akatsu T, Hiramori K. Activated tumour necrosis factor-alpha shedding process is associated with in-hospital complication in patients with acute myocardial infarction. Clin Sci (Lond) 2005; 108: 339-347.
38. Myerburg RJ, Mitrani R, Interian A Jr, Castellanos A. Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. Circulation 1998; 97: 1514-1521.
39. Gillum RF. Sudden coronary death in the United States: 1980-1985. Circulation 1989; 79: 756-765.